OCCHIO! BREAKING NEWS! K PANCREAS: PRIMO VACCINO CONTRO KRAS MUTANTE IN 20 PAZIENTI AD ALTO RISCHIO. DA ” CANCER DISCOVERY ” (FREE!)
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts S Daniel Haldar et al. Abstract Pancreatic ductal adenocarcinoma (PDAC) arises from precursor lesions over a decade-plus, offering a window for interception in high-risk individuals, but current surveillance detects a minority of precursors. Mutant KRAS (mKRAS) is present in most PDACs…

